Great meeting other Advocates from Greece, Germany and Switzerland tonight. Many of us have similar challenges across our countries and it is good to share thanks to ESMO’s patient Advocacy track. Stronger together. #ESMO24 METUPUK

Andrés Cervantes opened #ESMO24 celebrating 5 decades of ESMO as an organisation. “Oncologists need support at each part of their career….. Solidarity and strength, constant efforts to prepare for the future..”.

Good speaking with George Kapetanakis, President of Hellenic Cancer Federation about Metastatic Breast Cancer and discovering we are facing similar challenges for cancer patients across different countries. #ESMO24 METUP

Destiny-Breast12: One of the highlights at #ESMO24 presented by Nancy Lin, MD. Practice changing data for #mBC patients with HER+ disease and brain metastases. So finally patients with active brain metastases are being included in trials. OncoAlert

#CAPitello290 shows that an alteration alone (PIK3CA/AKT/PTEN) does not make a drug work in every subtype. But we need options for mTNBC! Could a different combination make a difference? Any thoughts? #ESMO24 #OncoAlert #TNBC OncoAlert

ESMO Patieny Advocacy Track speaker Natacha Bolanos Fernandez, “Advocacy isn’t just about speaking up - it’s about influencing decisions, shifting paradigms, and driving research”. #ESMO24 #METUPUK

ESMO Patient Advocacy Track; Sandrine Lavallé on Long Term side effects; brain fog, cardio toxicity, bone thinning, bone loss, fatigue, menopause symptoms and… uncertainty roche.com/stories/breast… #ESMO24 METUPUK

This is a real concern. T-DXd is a very effective drug for many patients. However, it seems that in the end it depends on where the tumor is being testet, what method is being used, and how it is interpreted whether patients are eligible to receive the drug 😨 #ESMO24 OncoAlert

DESTINY Breast 04, DAISY and DESTINY Breast 06 confer HER-2 low status is clinically targetable with Enhertu and patients with HR+, HER2-ultralow mBC derived clinically meaningful benefit from Enhertu vs the Physicians choice. #ESMO24 METUPUK

Peter A. Fasching, “In the NATALEE breast cancer trial, a dose reduction of Ribociclib did not impact efficacy…” #ESMO24 METUPUK

#ESMO24 METUPUK

Been running my #abcdretreat for 7 years now & have #nordicwalking groups around #greatermanchester for the last 2 years Supporting primary & metastatic #breastcancer patients This can easily be replicated (i have created a step by step guide how to do this & get it rolled

Jo Taylor Undoubtedly brilliant!! - and all the 5k Your Way, Move Against Cancer teams, Cancer United MoveMoreNI and many others doing great work in exercise. Problems remain in scaleability, multiple models and in persuading the unpersuaded (patients and HCPs!) #ESMO24

Great talks on metastatic breast cancer oligometastatic bone, brain and leptomeningeal disease Biological rationale for local therapy of oligoprogressive disease…. #ESMO24 METUPUK

Jo Taylor Oh no, Jo, they need to *study* it for 50 more years and THEN maybe they'll be ready to bust a move. Oy.🧐 Have you connected with Dr Prue Cormie? She's in Australia but is all over the exercise & #cancer research. Maybe she can be an ally in your efforts? cancer.org.au/people/prue-co…

Giampaolo Bianchini sums up MBC HER2 classifications for T-Dxd; IHC 0 assessments must be re-evaluated, one in four patients with local IHC 0 are improperly denied access to a very effective treatment #ESMO24 METUPUK

Greater Manchester Cancer Academy We can’t wait for this event our second conference on Metastatic breast cancer with the amazing Jo Taylor 🙌⭐️🙌 thanks for helping organise Tilly & Claire Goldrick

My top list of phrases that are not really patient friendly. #ESMO24 ❌ Grade 5 Events 🤨 ❌ AEs being manageable/tolerable 🥱 ❌ How to manage patients 😬 ❌ Patients = Subjects 🙄 ❌ Not clinically meaningful 🤔 Anyone want to continue the list? OncoAlert

METUPUK is in need of new #volunteers in #NorthernIreland! If you're based in NI and want to help improve things for patients with #metastaticbreastcancer, please get in touch: [email protected]

Cancer inputs this week - Telling my story for #BreastCancerAwarenessMonth to Thistle Foundation Webinar on Macmillan Cancer Support Boots partnership First meeting of Breast Cancer Now Secondary Advisory Group Now off to Jo Taylor exercise retreat! 💪🏻🏃🏻‍♀️🥵 TransPennine Express